Keep up to date with our news, press releases, and recent announcements.

Press American Society for Gastrointestinal Endoscopy Includes WATS3D in Its New Practice Guideline for the Screening and Surveillance of Barrett’s Esophagus SUFFERN, N.Y., (GLOBE NEWSWIRE), September 4, 2019 — CDx Diagnostics®, developer of the WATS3D diagnostic platform for the screening and surveillance …
Press Multicenter Prospective Study of More Than 4,000 Patients Shows WATS3D Increases Detection of Pre-Cancerous Changes in the Esophagus by Over 80% – Data published in United European Gastroenterology Journal and featured in new ASGE Tech Talk video –
Press CDx Diagnostics Announces Appointment of New CFO and Executive Vice President of Managed Care New Senior Leadership Sets Trajectory for 2018 WATS3D Commercial Expansion
Press New Data Demonstrate That WATS3D Is 4X More Effective Than the Seattle Random Biopsy Protocol in the Detection of High-Grade Dysplasia and Esophageal Adenocarcinoma Results From a Pivotal Prospective Randomized Crossover Study Conducted at 14 Major Academic Gastroenterology Centers to Be Presented at Digestive …
Press New Study Confirms High Inter-Observer Agreement Using the WATS3D Biopsy for Evaluation of Esophageal Pre-Cancer Provides Powerful Validation for the Clinical Value of Using the WATS3D Biopsy Procedure as a Complement to Four Quadrant Biopsy; Results Highlighted …
Press WATS3D Biopsy Increases Detection of Barrett’s Esophagus by 68.4% and Esophageal Dysplasia by 64.7% in Largest Study to Date Results of a Study of Over 2,500 Patients Who Received EGD in Community-Based Settings Highlighted in the Presidential Plenary Session at Digestive …

Get the latest posts in your email.

order kits Icon

Order Kits

Request additional test kits or patient materials.

Order Now

support icon


Let us help you with questions about our products and services. 

Request Support

lab services icon

Laboratory Services

Learn about the diagnostic assessments used in evaluating specimens.

Learn More